Friday - November 20, 2026
University at Buffalo: Inhaled Steroid Keeps COVID-19 Patients With Mild to Moderate Disease Out of the Hospital
November 23, 2021
BUFFALO, New York, Nov. 23 (TNSJou) -- The University at Buffalo (State University of New York) issued the following news release:

* * *

Conducted in late 2020, UB-led study of ciclesonide was one of the first to look at steroids in patients with mild to moderate disease

* * *

A national study led by emergency medicine physicians at the University at Buffalo has found that patients with mild to moderate COVID-19 who are treated with an inhaled . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products